Pasireotide Completed Phase 2 Trials for Hyperglycemia Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01128192Somatostatin Analogue SOM230 (Pasireotide) in Healthy Male Volunteers